Telemedicine programs are particularly suited to evaluating patients with Parkinson's
disease (PD) and other movement disorders, primarily because much of the physical exam …

Background Genome-wide association studies (GWAS) in Parkinson's disease have
increased the scope of biological knowledge about the disease over the past decade. We …

Abstract Purpose of Review The prevalence of neurodegenerative diseases, such as
Alzheimer's disease (AD) and Parkinson's disease (PD), is rising as the global population …

Background Increasing evidence supports an extensive and complex genetic contribution to
PD. Previous genome‐wide association studies (GWAS) have shed light on the genetic …

Genome-wide association studies have discovered hundreds of loci associated with
complex brain disorders, but it remains unclear in which cell types these loci are active. Here …

Gait analysis is crucial for the detection and management of various neurological and
musculoskeletal disorders. The identification of gait events is valuable for enhancing gait …

Objective Parkinson's disease (PD) is a neurodegenerative disorder with complex etiology.
Multiple genetic and environmental factors have been associated with PD, but most PD risk …

Aims To evaluate, using quantitative and qualitative approaches, published data on the
design and conduct of decentralised clinical trials (DCTs). Methods We searched MEDLINE …

Background: The public health measure restrictions across the world due to COVID-19 have
inadvertently impacted the routines for people with Parkinson's disease (PD) and their care …

Decentralized clinical trials (DCTs) are becoming increasingly popular. Digital clinical trial
platforms are software environments where users complete designated clinical trial tasks …